Global Competent Cells Market Growth (Status and Outlook) 2023-2029

Global Competent Cells Market Growth (Status and Outlook) 2023-2029

Competent cells are bacteria which can accept extra-chromosomal DNA or plasmids. Cells can be made competent in several ways. One such way is to "shock" it, which involves cooling the bacteria in a Calcium Chloride bath at 0 degrees Celsius, then quickly heating it to around 47 degrees Celsius for approximately 90 seconds (too long will denature the cell membrane, killing the bacteria). The calcium chloride ions neutralize the repulsion between the negatively charged phospholipid heads of the cell membrane and the negatively charged phosphate groups on the DNA. The quick heat shock creates a thermal gradient which, in turn, creates a draft leading into the cell, allowing extra-chromosomal DNA (such as plasmids) to enter the cell, allowing the bacterium to be genetically modifed.

LPI (LP Information)' newest research report, the “Competent Cells Industry Forecast” looks at past sales and reviews total world Competent Cells sales in 2022, providing a comprehensive analysis by region and market sector of projected Competent Cells sales for 2023 through 2029. With Competent Cells sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Competent Cells industry.

This Insight Report provides a comprehensive analysis of the global Competent Cells landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Competent Cells portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Competent Cells market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Competent Cells and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Competent Cells.

The global Competent Cells market size is projected to grow from US$ 1945.7 million in 2022 to US$ 3756.8 million in 2029; it is expected to grow at a CAGR of 9.9% from 2023 to 2029.

Global Competent Cells key players include Beijing TransGen Biotech, Merck KGaA, Thermo Fisher Scientific, Agilent Technologies, etc. Global top four manufacturers hold a share nearly 30%.

North America is the largest market, with a share about 10%, followed by Asia-Pacific and Europe, both have a share about 20 percent.

In terms of product, Chemically Competent Cells is the largest segment, with a share nearly 65%. And in terms of application, the largest application is Protein Expression, followed by Subcloning & Routine Cloning, Phage Display Library Construction, Toxic/Unstable DNA Cloning, etc.

This report presents a comprehensive overview, market shares, and growth opportunities of Competent Cells market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Chemically Competent Cells
Electrocompetent Cells

Segmentation by application
Subcloning & Routine Cloning
Phage Display Library Construction
Toxic/Unstable DNA Cloning
High-Throughput Cloning
Protein Expression
Mutagenesis
Single-Stranded DNA Production
Bacmid Creation
Cre-Lox Recombination (PIR1/PIR2)

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck KGaA
Thermo Fisher Scientific
Agilent Technologies
Takara Bio
Promega Corporation
Beijing TransGen Biotech
GeneScript Corporation
Yeastern Biotech
New England Biolabs
QIAGEN N.V.
OriGene Technologies
Lucigen
Zymo Research
Bio-Rad Laboratories
Bioline
Delphi Genetics
IBA GmBH
Cell Applications
BioDynamics Laboratory
Scarab Genomics
GCC Biotech
SMOBIO Technology
Edge BioSystems

Please note: The report will take approximately 2 business days to prepare and deliver.